About Belinda Laboratories Private Limited
Data last updated:
Belinda Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2011PTC220013. Its GSTIN is 07AAECB5599G1ZD (Delhi).
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹39.49 Cr. It is led by directors Abdurakhmon Karimov and Bezhan Mukimi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at X – 17 At Okhla Industrial Estate, Phase – II New Delhi – 110020, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.11 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹68.53 Lakh (net margin 11.2%) and EBITDA of ₹1.17 Cr (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 8% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website belinda.in.
Company details
Contact details
Belinda Laboratories Private Limited's registered office is in New Delhi, Delhi. Its website is belinda.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressX – 17 At Okhla Industrial Estate, Phase – II New Delhi – 110020, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Belinda Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Belinda Laboratories is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Belinda Laboratories Private Limited, buy the company report.
Financials of Belinda Laboratories Private Limited
FY 2024 filings availableBelinda Laboratories Private Limited reported revenue of ₹6.11 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 11% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.2% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Belinda Laboratories Private Limited, buy the company report.
Board of directors of Belinda Laboratories Private Limited
Belinda Laboratories has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdurakhmon Karimov Also directs: Belinda Private Limited | Director | 03 Jun 2015 | 11 Years 5 Months | Current |
| Bezhan Mukimi | Director | 01 Jun 2015 | 11 Years 5 Months | Current |
Auditor
Belinda Laboratories Private Limited is audited by RKACA & ASSOCIATES, LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RKACA & ASSOCIATES, LLP | FY 2023 | 014372N/N500004 |
Shareholding
The shareholding of Belinda Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Belinda Laboratories Private Limited, buy the company report.
Legal cases
Belinda Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Court case (TRF) | Filed against the company by State of Haryana | Disposed |
To see the full case history of Belinda Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Belinda Laboratories Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 55 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Excelsior Freight Solution Private Limited | |||
| Psychotropics India Limited | |||
| Rkca Corporate Advisory Private Limited | |||
| Skymap Healthcare Private Limited | |||
| Rkaca & Associates LLP |
To see the full MSME payment records of Belinda Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Belinda Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECB5599G1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Belinda Laboratories Private Limited, buy the company report.
Recent activity
Belinda Laboratories Private Limited has 11 board changes on record since 2011: 2 appointments and 9 cessations. The latest: Anis Komlov ceased to be Director on 02 Feb 2021.
2 earlier events are in the company report.
Frequently asked questions
Belinda Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 May 2011 (15+ years old) and is registered under CIN U33110DL2011PTC220013.
Belinda Laboratories has 2 current directors:
- Abdurakhmon Karimov - Director
- Bezhan Mukimi - Director
The latest financial statements of Belinda Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Belinda Laboratories is 07AAECB5599G1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Belinda Laboratories is U33110DL2011PTC220013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Belinda Laboratories has 1 court case on record: 1 filed against it.
Belinda Laboratories was incorporated on 30 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Anis Komlov ceased to be Director on 02 Feb 2021. Dilshod Kosimov ceased to be Additional Director on 29 Sep 2016. Abdurakhmon Karimov ceased to be Additional Director on 07 Sep 2015. Belinda Laboratories has 11 board changes on record in total.
Belinda Laboratories has 12 MSME Form 1 returns on record between 2019 and 2023, listing 55 overdue payments to 6 micro and small suppliers. The latest return was filed on 27 Aug 2023.
Belinda Laboratories can be reached through the website belinda.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Belinda Laboratories is at X – 17 At Okhla Industrial Estate, Phase – II New Delhi – 110020, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
